Irinotecan Hydrochloride
Overview
Irinotecan Hydrochloride is a topoisomerase inhibitor used in cancer therapy, particularly for colorectal cancer. It works by interfering with the DNA replication process, thereby inhibiting cell proliferation.
API suppliers (5)
Suppliers of Irinotecan Hydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 4 of 5 suppliers.
3 of 5 hold a GMP certificate on record in the EU or UK registers
- SCINOPHARM TAIWAN LTDTaiwan1 active DMF
- FERMION OYFinland1 active DMF GMP on record
- Hubei Haosun Pharmaceutical Co., Ltd.China1 active DMF GMP on record
- ALP PHARM BEIJING CO LTD
- Zhejiang Charioteer Pharmaceutical Co., Ltd.China GMP on record
Therapeutic areas
Do you supply Irinotecan Hydrochloride? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.